BOSCOLO BRAGADIN, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 731
NA - Nord America 613
EU - Europa 351
SA - Sud America 89
AF - Africa 84
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 1.881
Nazione #
US - Stati Uniti d'America 575
VN - Vietnam 238
SG - Singapore 200
IT - Italia 145
CN - Cina 98
BR - Brasile 52
HK - Hong Kong 40
NL - Olanda 28
FI - Finlandia 27
BD - Bangladesh 25
IN - India 25
DE - Germania 21
FR - Francia 20
GB - Regno Unito 13
SE - Svezia 12
CL - Cile 11
IQ - Iraq 11
PL - Polonia 11
RU - Federazione Russa 10
CI - Costa d'Avorio 9
CA - Canada 8
ES - Italia 8
TR - Turchia 8
DZ - Algeria 6
ID - Indonesia 6
PH - Filippine 6
PK - Pakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BJ - Benin 5
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
KH - Cambogia 5
KR - Corea 5
LA - Repubblica Popolare Democratica del Laos 5
MG - Madagascar 5
MK - Macedonia 5
MX - Messico 5
AR - Argentina 4
AT - Austria 4
AZ - Azerbaigian 4
GR - Grecia 4
PY - Paraguay 4
SA - Arabia Saudita 4
UA - Ucraina 4
UG - Uganda 4
AO - Angola 3
BF - Burkina Faso 3
BG - Bulgaria 3
CH - Svizzera 3
CM - Camerun 3
CO - Colombia 3
DK - Danimarca 3
DM - Dominica 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
MZ - Mozambico 3
NP - Nepal 3
PG - Papua Nuova Guinea 3
RW - Ruanda 3
YT - Mayotte 3
ZM - Zambia 3
AD - Andorra 2
AL - Albania 2
BZ - Belize 2
CR - Costa Rica 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
HT - Haiti 2
IR - Iran 2
IS - Islanda 2
JP - Giappone 2
KG - Kirghizistan 2
LC - Santa Lucia 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
MU - Mauritius 2
MW - Malawi 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SD - Sudan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
Totale 1.838
Città #
Ashburn 114
Singapore 109
Ho Chi Minh City 82
San Jose 71
Hanoi 50
Fairfield 36
Hong Kong 36
Chandler 35
Santa Clara 34
Padova 31
Da Nang 20
New York 20
Milan 18
Houston 16
Los Angeles 15
Haiphong 12
Helsinki 12
Beijing 10
Cambridge 10
Abidjan 9
Boardman 9
Wilmington 9
Woodbridge 9
Hefei 8
Lauterbourg 8
Munich 8
San Diego 8
São Paulo 8
Turku 8
Can Tho 7
Lappeenranta 7
Chennai 6
Chicago 6
Frankfurt am Main 6
Guangzhou 6
Seattle 6
Tashkent 6
Amsterdam 5
Ann Arbor 5
Antananarivo 5
Cotonou 5
London 5
Phnom Penh 5
Santiago 5
Seoul 5
Biên Hòa 4
Dallas 4
Hải Dương 4
Kampala 4
Kyiv 4
Medford 4
Mexico City 4
Naples 4
Orem 4
Pignone 4
Princeton 4
Rancho Palos Verdes 4
San Francisco 4
Venice 4
Vientiane 4
Willemstad 4
Athens 3
Baghdad 3
Buffalo 3
Bytom 3
Bến Tre 3
Castrezzato 3
City of London 3
Curitiba 3
Denver 3
Des Moines 3
Dhaka 3
Kigali 3
Lahore 3
Lusaka 3
Manchester 3
Montreal 3
Nuremberg 3
Phủ Từ Sơn 3
Port Moresby 3
Pune 3
Quận Hai 3
Redondo Beach 3
Rome 3
Roseau 3
Skopje 3
Tiền Hải 3
Warsaw 3
Wenzhou 3
Ấp Tháp Mười 3
Addis Ababa 2
Ahmedabad 2
Amman 2
Andorra la Vella 2
Asunción 2
Atlanta 2
Baku 2
Bishkek 2
Bogotá 2
Boston 2
Totale 1.076
Nome #
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 318
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 282
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 263
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 257
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors 224
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 199
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 194
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 163
Totale 1.900
Categoria #
all - tutte 4.912
article - articoli 4.912
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/202298 11 9 2 9 6 11 13 5 11 1 5 15
2022/202362 9 8 2 13 7 3 0 3 8 3 6 0
2023/202496 1 8 6 9 1 10 0 11 10 15 19 6
2024/2025331 6 39 12 16 39 9 7 43 30 15 45 70
2025/20261.237 72 84 124 168 93 51 317 74 136 59 59 0
Totale 1.900